<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37632118</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Associations of Serum Calprotectin, Arterial Stiffness and Long COVID Symptoms in Dalmatian Kidney Transplant Recipients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1776</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v15081776</ELocationID><Abstract><AbstractText>We aimed to explore long COVID symptoms, serum calprotectin levels, and the parameters of arterial stiffness in Dalmatian kidney transplant recipients (KTRs) and their possible associations. A cross-sectional, single-center case-control study on 98 KTRs who had recovered from COVID-19 was performed. Long COVID symptoms were explored via standardized questionnaires assessing quality of life, and serum calprotectin was also measured. Out of 98 KTRs with a mean age of 62 years, 63 (64.3%) were men. Medical history, clinical and laboratory parameters, and arterial stiffness measurements were obtained for each study participant. Difficulties with mobility were present in 44.3% of the KTRs, while difficulties with self-care were present in 6.2%, difficulties with usual activities were demonstrated by 35.1%, pain in the extremities was present in 52.5%, and anxiety and depression were present in 26.8%. Our results showed significant differences regarding serum calprotectin levels in clinical manifestations of acute COVID-19 and follow-up laboratory parameters. The most significant positive predictors of the serum calprotectin value in the KTRs were respiratory insufficiency, acute kidney failure, the prescription of antihypertensives, leukocyte and neutrophil counts, the neutrophil/lymphocyte ratio and lactate dehydrogenase levels. Negative predictors were the time since COVID-19, high-density lipoprotein levels, kidney function parameters, and the lymphocyte count. To conclude, serum calprotectin has emerged as a possible promising biomarker for subclinical allograft rejection; however, further studies are needed to better understand this subject.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>&#x110;oga&#x161;</LastName><ForeName>Tina</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Nephrology and Hemodialysis Division, University Hospital of Split, 21000 Split, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novak</LastName><ForeName>Ivana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Nephrology and Hemodialysis Division, University Hospital of Split, 21000 Split, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babi&#x107;</LastName><ForeName>Marija</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Nephrology and Hemodialysis Division, University Hospital of Split, 21000 Split, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vu&#x10d;kovi&#x107;</LastName><ForeName>Marijana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Nephrology and Hemodialysis Division, University Hospital of Split, 21000 Split, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tandara</LastName><ForeName>Leida</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Diagnostics, University Hospital of Split, University of Split School of Medicine, 21000 Split, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radi&#x107;</LastName><ForeName>Josipa</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2645-7597</Identifier><AffiliationInfo><Affiliation>Internal Medicine Department, Nephrology and Hemodialysis Division, University Hospital of Split, 21000 Split, Croatia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Split School of Medicine, 21000 Split, Croatia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D039841">Leukocyte L1 Antigen Complex</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016030" MajorTopicYN="Y">Kidney Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059289" MajorTopicYN="Y">Vascular Stiffness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039841" MajorTopicYN="N">Leukocyte L1 Antigen Complex</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">kidney rejection</Keyword><Keyword MajorTopicYN="N">kidney transplantation</Keyword><Keyword MajorTopicYN="N">long COVID pathophysiology</Keyword><Keyword MajorTopicYN="N">neutrophil activation</Keyword><Keyword MajorTopicYN="N">serum calprotectin</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37632118</ArticleId><ArticleId IdType="pmc">PMC10458603</ArticleId><ArticleId IdType="doi">10.3390/v15081776</ArticleId><ArticleId IdType="pii">v15081776</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus-de Jong C., Cleemput I., Van den Heede K. Pathophysiology and Mechanism of Long COVID: A Comprehensive Review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Blish C.A., Sallusto F., Iwasaki A. The Immunology and Immunopathology of COVID-19. Science. 2022;375:1122&#x2013;1127. doi: 10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R., Banerjee A., Baker M.R., Dani M., Ford E., Hull J.H., Lim P.B., McNarry M., Morten K., O&#x2019;Sullivan O., et al. Long COVID: Mechanisms, Risk Factors and Recovery. Exp. Physiol. 2023;108:12&#x2013;27. doi: 10.1113/EP090802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP090802</ArticleId><ArticleId IdType="pmc">PMC10103775</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif Z.A., Gomez C.R., Connors T.J., Henrich T.J., Reeves W.B. Pathogenic Mechanisms of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Elife. 2023;12:e86002. doi: 10.7554/eLife.86002.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86002</ArticleId><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Pellicer-Valero &#xd3;.J., Navarro-Pardo E., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Arias-Naval&#xf3;n J.A., Cigar&#xe1;n-M&#xe9;ndez M., Hern&#xe1;ndez-Barrera V., Arendt-Nielsen L. Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study. J. Clin. Med. 2022;11:413. doi: 10.3390/jcm11020413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., de Oliveira M.H.S., Peligro P.J., Velasco J.V., Macaranas I., Ver A.T., Pangilinan F.C., Pastrana A., Goldrich N., Kavteladze D., et al. Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis. J. Clin. Med. 2022;11:7314. doi: 10.3390/jcm11247314.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or Post-COVID-19 Syndrome: Putative Pathophysiology, Risk Factors, and Treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Amorim C.E.N., Gomes V.L.T., Cristelli M.P., Viana L.A., de Luca Correa H., Lima G.B.B., de Sousa Silva F.S., de Castro Lima G.S., Rosa T.d.S., Nakamura M.R., et al. High Prevalence of Long-COVID among Kidney Transplant Recipients: A Longitudinal Cohort Study. Transplantation. 2022;106:2408&#x2013;2415. doi: 10.1097/TP.0000000000004359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000004359</ArticleId><ArticleId IdType="pmc">PMC9696768</ArticleId><ArticleId IdType="pubmed">36228200</ArticleId></ArticleIdList></Reference><Reference><Citation>Basic-Jukic N., Juric I., Furic-Cunko V., Katalinic L., Radic J., Bosnjak Z., Jelakovic B., Kastelan Z. Follow-up of Renal Transplant Recipients after Acute COVID-19&#x2014;A Prospective Cohort Single-center Study. Immun. Inflamm. Dis. 2021;9:1563&#x2013;1572. doi: 10.1002/iid3.509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.509</ArticleId><ArticleId IdType="pmc">PMC8426882</ArticleId><ArticleId IdType="pubmed">34414665</ArticleId></ArticleIdList></Reference><Reference><Citation>Moody R., Sonda S., Johnston F.H., Smith K.J., Stephens N., McPherson M., Flanagan K.L., Plebanski M. Antibodies against Spike Protein Correlate with Broad Autoantigen Recognition 8 Months Post SARS-CoV-2 Exposure, and Anti-Calprotectin Autoantibodies Associated with Better Clinical Outcomes. Front. Immunol. 2022;13:945021. doi: 10.3389/fimmu.2022.945021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.945021</ArticleId><ArticleId IdType="pmc">PMC9403331</ArticleId><ArticleId IdType="pubmed">36032086</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a de Guadiana-Romualdo L., Rodr&#xed;guez Rojas C., Morell-Garc&#xed;a D., Andaluz-Ojeda D., Rodr&#xed;guez Mulero M.D., Rodr&#xed;guez-Borja E., Ballesteros-Vizoso A., Calvo M.D., Albert-Botella L., Pozo Gir&#xe1;ldez A., et al. Circulating Levels of Calprotectin, a Signature of Neutrophil Activation in Prediction of Severe Respiratory Failure in COVID-19 Patients: A Multicenter, Prospective Study (CalCov Study) Inflamm. Res. 2022;71:57&#x2013;67. doi: 10.1007/s00011-021-01516-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-021-01516-4</ArticleId><ArticleId IdType="pmc">PMC8556860</ArticleId><ArticleId IdType="pubmed">34718856</ArticleId></ArticleIdList></Reference><Reference><Citation>Mellett L., Khader S.A. S100A8/A9 in COVID-19 Pathogenesis: Impact on Clinical Outcomes. Cytokine Growth Factor Rev. 2022;63:90&#x2013;97. doi: 10.1016/j.cytogfr.2021.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2021.10.004</ArticleId><ArticleId IdType="pmc">PMC8520505</ArticleId><ArticleId IdType="pubmed">34728150</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetland G., Fagerhol M.K., Dimova-Svetoslavova V.P., Mirlashari M.R., Nguyen N.T., Lind A., Kolset S.O., S&#xf8;raas A.V.L., Nissen-Meyer L.S.H. Inflammatory Markers Calprotectin, NETs, Syndecan-1 and Neopterin in COVID-19 Convalescent Blood Donors. Scand. J. Clin. Lab. Investig. 2022;82:481&#x2013;485. doi: 10.1080/00365513.2022.2123387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365513.2022.2123387</ArticleId><ArticleId IdType="pubmed">36151851</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H., Zuo Y., Yalavarthi S., Gockman K., Zuo M., Madison J.A., Blair C., Woodward W., Lezak S.P., Lugogo N.L., et al. Neutrophil Calprotectin Identifies Severe Pulmonary Disease in COVID-19. J. Leukoc. Biol. 2021;109:67&#x2013;72. doi: 10.1002/JLB.3COVCRA0720-359R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3COVCRA0720-359R</ArticleId><ArticleId IdType="pmc">PMC7902293</ArticleId><ArticleId IdType="pubmed">32869342</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung D.-Y., Park J.B., Lee E.-N., Lee H.-A., Joh J.-W., Kwon C.H., Ki C.-S., Lee S.-Y., Kim S.-J. Combined Use of Myeloid-Related Protein 8/14 and Procalcitonin as Diagnostic Markers for Acute Allograft Rejection in Kidney Transplantation Recipients. Transpl. Immunol. 2008;18:338&#x2013;343. doi: 10.1016/j.trim.2007.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trim.2007.10.004</ArticleId><ArticleId IdType="pubmed">18158120</ArticleId></ArticleIdList></Reference><Reference><Citation>Str&#xed;z I., Jaresov&#xe1; M., L&#xe1;cha J., Sedl&#xe1;cek J., V&#xed;tko S. MRP 8/14 and Procalcitonin Serum Levels in Organ Transplantations. Ann. Transplant. 2001;6:6&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11803621</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhardt K., Radespiel-Tr&#xf6;ger M., Rupprecht H.D., Goppelt-Struebe M., Riess R., Renders L., Hauser I.A., Kunzendorf U. An Increase in Myeloid-Related Protein Serum Levels Precedes Acute Renal Allograft Rejection. J. Am. Soc. Nephrol. 2001;12:1947&#x2013;1957. doi: 10.1681/ASN.V1291947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.V1291947</ArticleId><ArticleId IdType="pubmed">11518789</ArticleId></ArticleIdList></Reference><Reference><Citation>Shokri-Afra H., Moradi M., Musavi H., Moradi-Sardareh H., Moradi Poodeh B., Kazemi Veisari A., Oladi Z., Ebrahimi M. Serum Calprotectin Can Indicate Current and Future Severity of COVID-19. J. Clin. Lab. Anal. 2023;37:e24809. doi: 10.1002/jcla.24809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.24809</ArticleId><ArticleId IdType="pmc">PMC9833977</ArticleId><ArticleId IdType="pubmed">36525302</ArticleId></ArticleIdList></Reference><Reference><Citation>Udeh R., Advani S., de Guadiana Romualdo L.G., Dolja-Gore X. Calprotectin, an Emerging Biomarker of Interest in COVID-19: A Systematic Review and Meta-Analysis. J. Clin. Med. 2021;10:775. doi: 10.3390/jcm10040775.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10040775</ArticleId><ArticleId IdType="pmc">PMC7919496</ArticleId><ArticleId IdType="pubmed">33672040</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A., Vojdani E., Saidara E., Maes M. Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Autoimmunity in Long COVID. Viruses. 2023;15:400. doi: 10.3390/v15020400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020400</ArticleId><ArticleId IdType="pmc">PMC9967513</ArticleId><ArticleId IdType="pubmed">36851614</ArticleId></ArticleIdList></Reference><Reference><Citation>Saif D.S., Ibrahem R.A., Eltabl M.A. Prevalence of Peripheral Neuropathy and Myopathy in Patients Post-COVID-19 Infection. Int. J. Rheum. Dis. 2022;25:1246&#x2013;1253. doi: 10.1111/1756-185X.14409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.14409</ArticleId><ArticleId IdType="pmc">PMC9538868</ArticleId><ArticleId IdType="pubmed">35915515</ArticleId></ArticleIdList></Reference><Reference><Citation>Mumtaz A., Sheikh A.A.E., Khan A.M., Khalid S.N., Khan J., Nasrullah A., Sagheer S., Sheikh A.B. COVID-19 Vaccine and Long COVID: A Scoping Review. Life. 2022;12:1066. doi: 10.3390/life12071066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12071066</ArticleId><ArticleId IdType="pmc">PMC9324565</ArticleId><ArticleId IdType="pubmed">35888154</ArticleId></ArticleIdList></Reference><Reference><Citation>Zisis S.N., Durieux J.C., Mouchati C., Perez J.A., McComsey G.A. The Protective Effect of Coronavirus Disease 2019 (COVID-19) Vaccination on Postacute Sequelae of COVID-19: A Multicenter Study From a Large National Health Research Network. Open Forum Infect. Dis. 2022;9:ofac228. doi: 10.1093/ofid/ofac228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac228</ArticleId><ArticleId IdType="pmc">PMC9129153</ArticleId><ArticleId IdType="pubmed">35818362</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., et al. Impact of COVID-19 Vaccination on the Risk of Developing Long-COVID and on Existing Long-COVID Symptoms: A Systematic Review. EClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Notarte K.I., Peligro P.J., Velasco J.V., Ocampo M.J., Henry B.M., Arendt-Nielsen L., Torres-Macho J., Plaza-Manzano G. Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature. Viruses. 2022;14:2629. doi: 10.3390/v14122629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez-Aceituno A., Garc&#xed;a-Hern&#xe1;ndez A., Larumbe-Zabala E. COVID-19 Long-Term Sequelae: Omicron versus Alpha and Delta Variants. Infect. Dis. Now. 2023;53:104688. doi: 10.1016/j.idnow.2023.104688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idnow.2023.104688</ArticleId><ArticleId IdType="pmc">PMC9970656</ArticleId><ArticleId IdType="pubmed">36858287</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A., Putrino D. Why We Need a Deeper Understanding of the Pathophysiology of Long COVID. Lancet Infect. Dis. 2023;23:393&#x2013;395. doi: 10.1016/S1473-3099(23)00053-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00053-1</ArticleId><ArticleId IdType="pmc">PMC9928485</ArticleId><ArticleId IdType="pubmed">36967698</ArticleId></ArticleIdList></Reference><Reference><Citation>Banko A., Miljanovic D., Cirkovic A. Systematic Review with Meta-Analysis of Active Herpesvirus Infections in Patients with COVID-19: Old Players on the New Field. Int. J. Infect. Dis. 2023;130:108&#x2013;125. doi: 10.1016/j.ijid.2023.01.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.01.036</ArticleId><ArticleId IdType="pmc">PMC9889115</ArticleId><ArticleId IdType="pubmed">36736577</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng A., Shah M., Ahmad S.A., Premraj L., Wildi K., Li Bassi G., Pardo C.A., Choi A., Cho S.-M. Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics. Cells. 2023;12:816. doi: 10.3390/cells12050816.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050816</ArticleId><ArticleId IdType="pmc">PMC10001044</ArticleId><ArticleId IdType="pubmed">36899952</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrhofer J., Graninger M., Lettenmaier L., Schweighardt J., Gentile S.A., Koidl L., Ret D., Stingl M., Puchhammer-St&#xf6;ckl E., Untersmayr E. Association between Epstein-Barr-Virus Reactivation and Development of Long-COVID Fatigue. Allergy. 2023;78:297&#x2013;299. doi: 10.1111/all.15471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15471</ArticleId><ArticleId IdType="pmc">PMC9538037</ArticleId><ArticleId IdType="pubmed">35950630</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottschalk C.G., Peterson D., Armstrong J., Knox K., Roy A. Potential Molecular Mechanisms of Chronic Fatigue in Long Haul COVID and Other Viral Diseases. Infect. Agent. Cancer. 2023;18:7. doi: 10.1186/s13027-023-00485-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13027-023-00485-z</ArticleId><ArticleId IdType="pmc">PMC9902840</ArticleId><ArticleId IdType="pubmed">36750846</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou E., Lampsas S., Theofilis P., Souvaliotis N., Papamikroulis G.A., Katsarou O., Kalogeras K., Pantelidis P., Papaioannou T.G., Tsatsaragkou A., et al. Impaired Left Ventricular Deformation and Ventricular-Arterial Coupling in Post-COVID-19: Association with Autonomic Dysregulation. Heart Vessels. 2023;38:381&#x2013;393. doi: 10.1007/s00380-022-02180-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00380-022-02180-2</ArticleId><ArticleId IdType="pmc">PMC9516516</ArticleId><ArticleId IdType="pubmed">36169708</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanoli L., Gaudio A., Mikhailidis D.P., Katsiki N., Castellino N., Lo Cicero L., Geraci G., Sessa C., Fiorito L., Marino F., et al. Vascular Dysfunction of COVID-19 Is Partially Reverted in the Long-Term. Circ. Res. 2022;130:1276&#x2013;1285. doi: 10.1161/CIRCRESAHA.121.320460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.320460</ArticleId><ArticleId IdType="pubmed">35345906</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammoul M., Naddour J., Madi A., Reslan M.A., Hatoum F., Zeineddine J., Abou-Kheir W., Lawand N. Investigating the Possible Mechanisms of Autonomic Dysfunction Post-COVID-19. Auton. Neurosci. 2023;245:103071. doi: 10.1016/j.autneu.2022.103071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2022.103071</ArticleId><ArticleId IdType="pmc">PMC9789535</ArticleId><ArticleId IdType="pubmed">36580747</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai A.D., Lavelle M., Boursiquot B.C., Wan E.Y. Long-Term Complications of COVID-19. Am. J. Physiol.-Cell Physiol. 2022;322:C1&#x2013;C11. doi: 10.1152/ajpcell.00375.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahrooz A., Muscogiuri G., Buzzetti R., Maddaloni E. The Complex Combination of COVID-19 and Diabetes: Pleiotropic Changes in Glucose Metabolism. Endocrine. 2021;72:317&#x2013;325. doi: 10.1007/s12020-021-02729-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02729-7</ArticleId><ArticleId IdType="pmc">PMC8060688</ArticleId><ArticleId IdType="pubmed">33886062</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing H., Wu X., Xiang M., Liu L., Novakovic V.A., Shi J. Pathophysiological Mechanisms of Thrombosis in Acute and Long COVID-19. Front. Immunol. 2022;13:992384. doi: 10.3389/fimmu.2022.992384.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.992384</ArticleId><ArticleId IdType="pmc">PMC9709252</ArticleId><ArticleId IdType="pubmed">36466841</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogas T., Brkovic T., Novak I., Radic J. COVID-19 in Kidney Transplant Recipients; a DALMATIAN Single-center Experience. Ther. Apher. Dial. 2023;27:107&#x2013;116. doi: 10.1111/1744-9987.13894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1744-9987.13894</ArticleId><ArticleId IdType="pmc">PMC9347706</ArticleId><ArticleId IdType="pubmed">35684944</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimova E.M., Bozhkov A.I., Lavinska O.V., Drozdova L.A., Kurhuzova N.I. Low molecular weight cytotoxic components (DAMPs) form the post-COVID-19 syndrome. Immunobiology. 2023;228:152316. doi: 10.1016/j.imbio.2022.152316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2022.152316</ArticleId><ArticleId IdType="pmc">PMC9764760</ArticleId><ArticleId IdType="pubmed">36565610</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin R., He L., Yang Z., Jia N., Chen R., Xie J., Fu W., Chen H., Lin X., Huang R., et al. Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: A Systematic Review and Meta-analysis. Clin. Rev. Allergy Immunol. 2022;64:33&#x2013;65. doi: 10.1007/s12016-021-08908-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-021-08908-8</ArticleId><ArticleId IdType="pmc">PMC8763427</ArticleId><ArticleId IdType="pubmed">35040086</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahrini K., Stambouli N., Ben Azaiez M., Rebai A., Abid F., Romdhani C., Labben I., Gharsallah H., Ferjani M. Immune Cell Response during COVID-19 Infection and following SARS-CoV-2 Vaccination in Patients Admitted to Intensive Care Unit. J. Immunol. Res. 2023;2023:4059484. doi: 10.1155/2023/4059484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/4059484</ArticleId><ArticleId IdType="pmc">PMC10151725</ArticleId><ArticleId IdType="pubmed">37144176</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohseni Afshar Z., Barary M., Babazadeh A., Tavakoli Pirzaman A., Hosseinzadeh R., Alijanpour A., Allahgholipour A., Miri S.R., Sio T.T., Sullman M.J., et al. The role of cytokines and their antagonists in the treatment of COVID-19 patients. Rev. Med. Virol. 2023;33:e2372. doi: 10.1002/rmv.2372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2372</ArticleId><ArticleId IdType="pmc">PMC9347599</ArticleId><ArticleId IdType="pubmed">35621229</ArticleId></ArticleIdList></Reference><Reference><Citation>Gholinataj Jelodar M., Rafieian S., Saghafi F., Hadad Zedegan N., Birjandi B., Rafieian S., Allah Dini A., Dehghanpour H., Khalaj F., Zare S., et al. Efficacy and safety of Tocilizumab, plasmapheresis and their combination in severe COVID-19: A randomized clinical trial. Int. Immunopharmacol. 2023;115:109623. doi: 10.1016/j.intimp.2022.109623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2022.109623</ArticleId><ArticleId IdType="pmc">PMC9767880</ArticleId><ArticleId IdType="pubmed">36577157</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahini A., Shahini A. Role of interleukin-6-mediated inflammation in the pathogenesis of inflammatory bowel disease: Focus on the available therapeutic approaches and gut microbiome. J. Cell Commun. Signal. 2023;17:55&#x2013;74. doi: 10.1007/s12079-022-00695-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12079-022-00695-x</ArticleId><ArticleId IdType="pmc">PMC10030733</ArticleId><ArticleId IdType="pubmed">36112307</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>